EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection

Jingke Geng, Nanjie Ren, Cihan Yang, Fei Wang, Doudou Huang, Sergio Rodriguez, Zhiming Yuan iD, Han Xia iD

Viruses · 2024

DOI: 10.3390/v16040631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Jingke Geng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430200, China. Hauptthemen laut MEDLINE: Pyrazines, Amides, Antiviral Agents, Mice, Inbred BALB C. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Program of Wuhan Institute of Virology, National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthobunyavirus is the largest and most diverse genus in the family Peribunyaviridae. Orthobunyaviruses are widely distributed globally and pose threats to human and animal health. Ebinur Lake virus (EBIV) is a newly classified Orthobunyavirus detected in China, Russia, and Kenya. This study explored the antiviral effects of two broad-spectrum antiviral drugs, favipiravir and ribavirin, in a BALB/c mouse model. Favipiravir significantly improved the clinical symptoms of infected mice, reduced viral titer and RNA copies in serum, and extended overall survival. The median survival times of mice in the vehicle- and favipiravir-treated groups were 5 and 7 days, respectively. Favipiravir significantly reduced virus titers 10- to 100-fold in sera at all three time points compared to vehicle-treated mice. And favipiravir treatment effectively reduced the virus copies by approximately 10-fold across the three time points, relative to vehicle-treated mice. The findings expand the antiviral spectrum of favipiravir for orthobunyaviruses in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazinesAmidesAntiviral AgentsMice, Inbred BALB CDisease Models, AnimalViral LoadAnimalsMiceFemaleRibavirinRNA Virus Infections

Stichwörter der Autor:innen

Ebinur Lake virusfavipiravirmouse modelribavirin

Substanzen

favipiravirPyrazinesAmidesAntiviral AgentsRibavirin

Autor:innen und Institutionen

  • Key Laboratory of Virology and Biosafety, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430200, China.
  • University of Chinese Academy of Sciences, Beijing 101408, China.
  • Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77551, USA.
  • Hubei Jiangxia Laboratory, Wuhan 430207, China.

ORCID-Profile: Zhiming Yuan, Han Xia

Förderung

  • Youth Program of Wuhan Institute of Virology
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Geng, J., Ren, N., Yang, C., Wang, F., Huang, D., Rodriguez, S., Yuan, Z., & Xia, H. (2024). Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection. Viruses. https://doi.org/10.3390/v16040631

Vancouver

Geng J, Ren N, Yang C, Wang F, Huang D, Rodriguez S, et al. Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection. Viruses. 2024. doi:10.3390/v16040631

BibTeX
@article{Geng2024,
  author = {Geng, Jingke and Ren, Nanjie and Yang, Cihan and Wang, Fei and Huang, Doudou and Rodriguez, Sergio and Yuan, Zhiming and Xia, Han},
  title = {Favipiravir Treatment Prolongs Survival in a Lethal BALB/c Mouse Model of Ebinur Lake Virus Infection},
  journal = {Viruses},
  year = {2024},
  doi = {10.3390/v16040631}
}
Kostenlos starten →